<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Drug Discovery and Development Industry: Market Research Reports, Statistics and Analysis]]></title>
    <link>http://www.reportlinker.com/ci02259/Drug-Discovery-and-Development.html</link>
    <description><![CDATA[Reportlinker.com Lastest Drug Discovery and Development Industry: Market Research Reports, Statistics and Analysis]]></description>
    <pubDate>Fri, 24 May 2013 17:12:15 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Company Report: Drug Discovery and Development in China for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014265688/Company-Report-Drug-Discovery-and-Development-in-China-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014265688/Company-Report-Drug-Discovery-and-Development-in-China-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Refund : after completion of phase ii trial, if jiangsu neptunus decides not to  proceed with the next <strong>clinical</strong> <strong>trial</strong> by reason of safety and effectiveness of  the recombinant technology, shenzhen neptunus ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Lorus Therapeutics Inc. - Company Report for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014258492/Lorus-Therapeutics-Inc-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014258492/Lorus-Therapeutics-Inc-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Of additional  quantities of lor-253, increased clinical costs associated with the lor-253 phase i <strong>clinical</strong> <strong>trial</strong> as well as  spending on our il-17e and lor-500 programs initiated and escalated in the current ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Evotec AG - Company Report for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014236814/Evotec-AG-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014236814/Evotec-AG-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Screening,  <strong>compound</strong> <strong>management</strong>, fragmentierte wirkstoffforschung, medizinalchemie und in-vivo- pharmakologie, in-vivo-admet-assays sowie eine chemische proteomik-plattform. Dazu  hat das unternehmen eine ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Drug Discovery in France and Germany for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014266819/Company-Report-Drug-Discovery-in-France-and-Germany-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014266819/Company-Report-Drug-Discovery-in-France-and-Germany-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Health will drive forward public health knowledge, which is a key issue for all governments."    The french-german advanced translational <strong>drug</strong> <strong>discovery</strong> center is a unique project of public- private ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Drug Discovery and Development in China for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014301788/Company-Report-Drug-Discovery-and-Development-in-China-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014301788/Company-Report-Drug-Discovery-and-Development-in-China-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... D productivity by shortening <strong>drug-development</strong> times and delivering the  highest-quality services. We work with our customers to provide them with the capabilities and capacity they  need throughout the drug ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Clinical Trial in Japan : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d014236336/Clinical-Trial-in-Japan-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014236336/Clinical-Trial-in-Japan-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... And insurance for <strong>clinical</strong>  <strong>research</strong> besides trials  a lot of <strong>clinical</strong> <strong>research</strong> not covered by the pharmaceutical  affairs act is conducted in many education-related hospitals  such as university hospitals ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Sector  in The United States and Singapore]]></title>
      <link>http://www.reportlinker.com/d014252509/Drug-Discovery-and-Development-Sector-in-The-United-States-and-Singapore.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014252509/Drug-Discovery-and-Development-Sector-in-The-United-States-and-Singapore.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Progression modelling at gsk, uk and chdr, the netherlands danny lowe, cfo part time: previously cfo for several public companies in the <strong>drug</strong> <strong>discovery</strong>, alternative energy and  mineral resources sector advisors ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Singaporean Drug Discovery and Development Business : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d014351144/The-Singaporean-Drug-Discovery-and-Development-Business-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014351144/The-Singaporean-Drug-Discovery-and-Development-Business-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... China & india  india      (reassessment of previous  aggressive strategies)  independent expert  committees: feb 2013 to  formulate guidelines:   Approval of new drugs   <Strong>clinical</strong> <strong>trials</strong>   Banning of drugs ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Singaporean Drug Discovery and Development Business : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d014351453/The-Singaporean-Drug-Discovery-and-Development-Business-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014351453/The-Singaporean-Drug-Discovery-and-Development-Business-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... The press  key challenges in pharmaceutical  industry  increase in cost of <strong>drug</strong>  <strong>discovery</strong> & development  increasing time to market  impending patent  expirations of blockbuster  molecules   pricing pressure ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Clinical Research : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d014344908/Clinical-Research-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014344908/Clinical-Research-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Services. Contact him at 1.650.465.0119 Or   figure 1. Supply and demand for <strong>clinical</strong> <strong>research</strong> personnel (2012/2013)       ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Middle East & Africa Pharmaceutical & Healthcare Reports]]></title>
      <link>http://www.reportlinker.com/p01117725/The-Middle-East-Africa-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01117725/The-Middle-East-Africa-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> Espicom market intelligence, brought to you by Business Monitor International The Middle East & Africa Pharmaceuticals & Healthcare Reports feature independent forecasts for drugs and healthcare expenditure ...]]></description>
      <pubDate>Wed, 27 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Asian Pharmaceuticals and Healthcare Reports]]></title>
      <link>http://www.reportlinker.com/p01117723/Asian-Pharmaceuticals-and-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01117723/Asian-Pharmaceuticals-and-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> Espicom market intelligence, brought to you by Business Monitor International WHY THESE REPORTS ARE IMPORTANT Despite on-going economic pressures, the pharmaceutical industry is one of the most successful ...]]></description>
      <pubDate>Wed, 27 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Americas Pharmaceutical & Healthcare Reports]]></title>
      <link>http://www.reportlinker.com/p01117724/The-Americas-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01117724/The-Americas-Pharmaceutical-Healthcare-Reports.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> Espicom market intelligence, brought to you by Business Monitor International The Americas Pharmaceuticals & Healthcare Reports feature independent forecasts for drugs and healthcare expenditure and imports ...]]></description>
      <pubDate>Wed, 27 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery]]></title>
      <link>http://www.reportlinker.com/p01155360/Histone-Methyltransferases-Global-Markets-for-Research-Tools-Diagnostics-and-Drug-Discovery.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01155360/Histone-Methyltransferases-Global-Markets-for-Research-Tools-Diagnostics-and-Drug-Discovery.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1291.gif"> REPORT SCOPE INTRODUCTION STUDY GOALS AND OBJECTIVES This BCC Research report, Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery, provides an overview of the ...]]></description>
      <pubDate>Thu, 21 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech]]></title>
      <link>http://www.reportlinker.com/p01181010/Discovery-Preclinical-and-Clinical-Stage-Partnering-Terms-and-Agreements-in-Pharma-and-Biotech.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181010/Discovery-Preclinical-and-Clinical-Stage-Partnering-Terms-and-Agreements-in-Pharma-and-Biotech.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1325.gif"> The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Ion Channel Modulators Industry]]></title>
      <link>http://www.reportlinker.com/p01171462/Global-Ion-Channel-Modulators-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01171462/Global-Ion-Channel-Modulators-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1215.gif"> This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, ...]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Biologicals in Oncology Drug Pipeline Update 2013]]></title>
      <link>http://www.reportlinker.com/p0379872/Biologicals-in-Oncology-Drug-Pipeline-Update.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0379872/Biologicals-in-Oncology-Drug-Pipeline-Update.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1495.gif"> This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 860 companies plus partners developing 1460 biological ...]]></description>
      <pubDate>Sun, 21 Apr 2013 22:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
